Learning Objectives:

  1. To understand current guidelines and recommendations for use of SGLT2-inhibitors for patients with diabetic kidney disease Review principles of effective community-engaged research
  2. To learn about one approach to initiating and monitoring the use of SGLT2-inhibitors in patients with DKD
Session date: 
11/13/2020 - 12:00pm to 1:00pm CST
Zoom meeting
5700 S Maryland Ave
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Julie Paik, MD, ScD, MPH